Hindustan Unilever Ltd
Hindustan Unilever Ltd
FMCG F&OKey Fundamentals
LargecapDiversified FMCGFMCGInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Hindustan Unilever Ltd insights
49 extracted metrics + investor summaries across FY09–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
2- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 92.4%
Weaknesses
3- Stock is trading at 10.0 times its book value
- The company has delivered a poor sales growth of 6.51% over past five years.
- Earnings include an other income of Rs.4,933 Cr.
Growth Rate
AI Analysis — Bull vs Bear
Hindustan Unilever Ltd commands a market cap of ₹4,83,687 Cr with a PE of 32.3x and dividend yield of 1.99%. The company is nearly debt-free with a last-year ROE of 31%, but top-line growth has been sluggish at 2% CAGR over 3 years and the stock has declined 14% over the past year.
- Company is almost debt-free, providing significant financial flexibility and resilience during economic downturns
- ROE of 31% in the last year demonstrates strong capital efficiency, well above the 5-year average of 22%
- Consistent dividend payout of 92.4% with a current yield of 1.99%, offering reliable income to shareholders
- Compounded profit growth of 14% over 10 years shows sustained long-term earnings compounding ability
- 10-year stock CAGR of 9% reflects long-term wealth creation despite recent weakness
- TTM profit growth of 4% remains positive even in a period of muted revenue expansion, indicating margin management discipline
- 5-year compounded profit growth of 13% has significantly outpaced 5-year sales growth of 7%, reflecting operating leverage and cost control
- Stock is trading at 9.95x book value, a steep premium that leaves limited margin of safety
- 3-year compounded sales growth of just 2% signals persistent demand weakness in core FMCG categories
- Stock has declined 14% over the past 1 year, underperforming broader market indices significantly
- Earnings include other income of ₹4,933 Cr, raising questions about the quality and sustainability of reported profits
- 5-year stock CAGR of -2% indicates prolonged shareholder value erosion on a medium-term basis
- PE of 32.3x is expensive relative to the modest TTM sales growth of 6%, implying stretched valuations
- 5-year sales growth of approximately 6.5-7% barely keeps pace with nominal GDP growth, suggesting market share stagnation
- 3-year stock CAGR of -5% indicates sustained de-rating by the market despite profit growth of 14% over the same period
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Q1FY27 revenue up 10% Aug 4
HUL reported 10% underlying sales growth in Q1FY27 driven by volume and price. EBITDA margin held steady at 23% despite commodity inflation, with adjusted PAT rising 11%.
- Q1FY26 highest growth in 13 quarters Jul 28
HUL posted 10% USG and ₹17,184 crore turnover in Q1FY26, the highest growth in 13 quarters. EBITDA grew 8% to ₹3,947 crore, though PAT dipped 2% due to a prior-year one-off tax credit.
- Capital Markets Day on Sep 4 Jul 28
HUL will host Capital Markets Day 2026 on September 4 for institutional investors and analysts to update on strategic direction.
- Q1FY27 earnings call scheduled Jul 22
Hindustan Unilever scheduled its Q1FY27 earnings conference call for July 28, 2026.
TL;DR: HUL is delivering consistent double-digit underlying sales growth across consecutive quarters, with EBITDA margins holding at 23% despite commodity inflation. No material headwinds are visible in recent news flow, and volume-led growth signals healthy demand. The upcoming Capital Markets Day on Sep 4 could provide further catalysts if management outlines an upgraded medium-term growth framework.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 15,496 | 15,623 | 15,567 | 15,210 | 15,707 | 15,926 | 15,556 | 15,190 | 15,757 | 15,919 | 16,441 | 16,351 | 17,341 |
| Expenses | 11,832 | 11,828 | 11,902 | 11,675 | 11,965 | 12,139 | 11,867 | 11,572 | 12,118 | 12,137 | 12,660 | 12,514 | 13,394 |
| Operating Profit | 3,664 | 3,795 | 3,665 | 3,535 | 3,742 | 3,787 | 3,689 | 3,618 | 3,639 | 3,782 | 3,781 | 3,837 | 3,947 |
| OPM % | 24% | 24% | 24% | 23% | 24% | 24% | 24% | 24% | 23% | 24% | 23% | 23% | 23% |
| Other Income | 146 | 178 | 184 | 309 | 209 | 203 | 733 | 149 | 103 | 269 | 4,048 | 503 | 113 |
| Interest | 50 | 88 | 91 | 105 | 93 | 110 | 109 | 77 | 122 | 124 | 88 | 76 | 75 |
| Depreciation | 286 | 297 | 313 | 320 | 329 | 338 | 318 | 318 | 326 | 322 | 337 | 348 | 353 |
| PBT | 3,474 | 3,588 | 3,445 | 3,419 | 3,529 | 3,542 | 3,995 | 3,372 | 3,294 | 3,605 | 7,404 | 3,916 | 3,632 |
| Tax % | 26% | 26% | 27% | 25% | 26% | 27% | 25% | 27% | 16% | 25% | 11% | 24% | 26% |
| Net Profit | 2,556 | 2,657 | 2,508 | 2,561 | 2,612 | 2,595 | 2,989 | 2,475 | 2,768 | 2,694 | 6,603 | 2,994 | 2,680 |
| EPS in Rs | 10.87 | 11.3 | 10.68 | 10.89 | 11.11 | 11.03 | 12.7 | 10.49 | 11.73 | 11.43 | 28.12 | 12.73 | 11.38 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 31,972 | 32,186 | 33,162 | 35,545 | 39,310 | 39,783 | 47,028 | 52,446 | 60,580 | 61,896 | 61,328 | 64,468 | 66,052 |
| Expenses | 26,560 | 26,276 | 26,834 | 28,046 | 30,430 | 29,922 | 35,402 | 39,589 | 46,433 | 47,237 | 46,630 | 49,429 | 50,705 |
| Operating Profit | 5,412 | 5,910 | 6,328 | 7,499 | 8,880 | 9,861 | 11,626 | 12,857 | 14,147 | 14,659 | 14,698 | 15,039 | 15,347 |
| OPM % | 17% | 18% | 19% | 21% | 23% | 25% | 25% | 25% | 23% | 24% | 24% | 23% | 23% |
| Other Income | 1,247 | 486 | 606 | 353 | 322 | 424 | 170 | 219 | 448 | 817 | 1,355 | 4,923 | 4,933 |
| Interest | 18 | 17 | 35 | 26 | 33 | 118 | 117 | 106 | 114 | 334 | 381 | 410 | 363 |
| Depreciation | 322 | 353 | 432 | 520 | 565 | 1,002 | 1,074 | 1,091 | 1,137 | 1,216 | 1,253 | 1,333 | 1,360 |
| PBT | 6,320 | 6,026 | 6,467 | 7,306 | 8,604 | 9,165 | 10,605 | 11,879 | 13,344 | 13,926 | 14,419 | 18,219 | 18,557 |
| Tax % | 31% | 31% | 31% | 28% | 30% | 26% | 25% | 25% | 24% | 26% | 26% | 17% | — |
| Net Profit | 4,376 | 4,151 | 4,490 | 5,227 | 6,060 | 6,756 | 7,999 | 8,892 | 10,143 | 10,282 | 10,671 | 15,059 | 14,971 |
| EPS in Rs | 20.17 | 19.18 | 20.68 | 24.09 | 27.97 | 31.17 | 34.03 | 37.79 | 43.07 | 43.74 | 45.32 | 64.01 | 63.66 |
| Div. Payout % | 74% | 83% | 82% | 83% | 78% | 80% | 119% | 90% | 91% | 96% | 117% | 64% | — |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 216 | 216 | 216 | 216 | 216 | 216 | 235 | 235 | 235 | 235 | 235 | 235 |
| Reserves | 3,811 | 6,357 | 6,528 | 7,065 | 7,651 | 8,013 | 47,439 | 48,826 | 50,069 | 50,983 | 49,167 | 48,504 |
| Borrowings | 43 | 177 | 277 | 0 | 99 | 0 | 0 | 1,043 | 1,219 | 1,484 | 1,648 | 1,478 |
| Other Liabilities | 10,359 | 8,043 | 8,685 | 10,581 | 10,663 | 11,924 | 21,066 | 20,402 | 21,554 | 25,787 | 28,813 | 29,521 |
| Total Liabilities | 14,430 | 14,793 | 15,706 | 17,862 | 18,629 | 20,153 | 68,740 | 70,506 | 73,077 | 78,489 | 79,863 | 79,738 |
| Fixed Assets | 2,821 | 3,258 | 4,419 | 4,528 | 4,715 | 5,479 | 51,443 | 51,473 | 52,678 | 53,744 | 54,335 | 57,428 |
| CWIP | 516 | 408 | 229 | 461 | 406 | 597 | 745 | 1,313 | 1,132 | 1,025 | 1,009 | 880 |
| Investments | 3,025 | 2,592 | 3,794 | 2,873 | 2,716 | 1,255 | 2,709 | 3,521 | 2,882 | 4,625 | 3,810 | 4,359 |
| Other Assets | 8,067 | 8,535 | 7,264 | 10,000 | 10,792 | 12,822 | 13,843 | 14,199 | 16,385 | 19,095 | 20,709 | 17,071 |
| Total Assets | 14,430 | 14,793 | 15,706 | 17,862 | 18,629 | 20,153 | 68,740 | 70,506 | 73,077 | 78,489 | 79,863 | 79,738 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 3,292 | 4,171 | 5,185 | 6,059 | 5,800 | 7,623 | 9,163 | 9,048 | 9,991 | 15,469 | 11,886 | 10,999 |
| Investing | 138 | -282 | -1,173 | -1,063 | -438 | 1,791 | -1,228 | -1,728 | -1,484 | -5,324 | 6,473 | -3,676 |
| Financing | -3,462 | -3,864 | -4,214 | -4,975 | -5,390 | -6,819 | -9,309 | -8,015 | -8,953 | -10,034 | -13,101 | -10,810 |
| Net Cash Flow | -33 | 25 | -202 | 21 | -28 | 2,595 | -1,374 | -695 | -446 | 111 | 5,258 | -3,487 |
| Free Cash Flow | 3,246 | 3,460 | 4,248 | 5,196 | 5,046 | 6,813 | 5,097 | 7,995 | 8,980 | 14,012 | 10,624 | 9,667 |
| CFO/OP | 95 | 100 | 111 | 111 | 96 | 103 | 100 | 92 | 93 | 108 | 96 | 105 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 12 | 14 | 12 | 13 | 17 | 11 | 14 | 16 | 19 | 18 | 23 | 19 |
| Inventory Days | 77 | 75 | 67 | 65 | 59 | 65 | 66 | 65 | 55 | 55 | 61 | 61 |
| Days Payable | 148 | 156 | 164 | 185 | 166 | 176 | 163 | 145 | 123 | 143 | 156 | 169 |
| Cash Conversion Cycle | -60 | -67 | -85 | -107 | -90 | -101 | -83 | -64 | -50 | -70 | -72 | -89 |
| Working Capital Days | -53 | -26 | -35 | -37 | -30 | -31 | -32 | -22 | -15 | -22 | -34 | -23 |
| ROCE % | 139% | 112% | 91% | 103% | 116% | 117% | 39% | 25% | 27% | 27% | 28% | 28% |
Documents
Frequently Asked Questions about Hindustan Unilever Ltd
What does Hindustan Unilever Ltd do?
Where is Hindustan Unilever Ltd (HINDUNILVR) listed?
Which sector does Hindustan Unilever Ltd belong to?
What is the market capitalisation of Hindustan Unilever Ltd?
What is the PE ratio of Hindustan Unilever Ltd?
What is the 52-week high and low of Hindustan Unilever Ltd?
Does Hindustan Unilever Ltd pay dividends?
What is the Return on Equity (ROE) of Hindustan Unilever Ltd?
How can I research Hindustan Unilever Ltd on Tapetide?
Company Information
Hindustan Unilever is in the FMCG business comprising primarily of Home Care, Beauty & Personal Care and Foods & Refreshment segments. The Company has manufacturing facilities across the country and sells primarily in India.[1]